eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
1/2001
vol. 5
 
Share:
Share:
more
 
 
abstract:

Diagnosis and treatment of pneumonia in the immunocompromised patient

Elżbieta Nowak
,
Rodryg Ramlau
,
Tomasz Ozorowski

Współcz Onkol (2001) vol. 5, 1 (17-18)
Online publish date: 2003/07/09
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Broad diagnostic process is usually required for pneumonia in immunocompromised patient. Protected bronchoscopic or non-bronchoscopic methods (PBS or PBL) should be used for bacterial infection. Detection of galactomanian antigen can be used for Aspergillus, when infection caused by Candida albicans is suspected invasive methods, lung biopsy or videothoracoscopy, are most useful. DFA is used for detection of Pneumocystis carinii infection. PCR-DNA or detection of pp65 antigen are reliable methods for detection of CMV. X-ray picture of the lung can be helpful when treatment is empirical. When infiltrate is localised, common bacterial pulmonary pathogens should be suspected and III generation cephalosporin might be a drug of choice. Fungal infection usually produce nodular infiltrate. When diffuse abnormalities have occurred viral, Chlamydial or Pneumocystis carinii infection can be suspected and combination of trimethoprim/sulfamethoxazol, erythromycin and antiviral drug is used.
keywords:

pneumonia, immunodeficiency

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe